Roche NimbleGen and the California-based BioDiscovery have formed a strategic alliance to help genomic researchers more quickly arrive at important biological insights. Under the partnership, they will combine their technologies to offer a more complete analytical solution to genomic and life-science customers. Roche NimbleGen was...
Mediocre therapeutic results against a cancer that no other therapy has shown much success against does not mean that RNase-based therapies, such as the one being developed by Madison's Quintessence Biosciences, will not be effective against other types of cancers. In this edition of Biotech...
The Madison-based biopharmaceutical firm Centrose continues to make progress toward developing therapies for cancer. The company has announced that two of its lead drug candidates have demonstrated, in animal models, the ability to kill cancer cells in colorectal and non-small lung cancers. Centrose, which will...
Spurred on by the 2007 acquisition of Madison's NimbleGen by the pharma giant Roche, Wisconsin officials and biotech companies are on the hunt for additional collaborations with large pharmaceutical firms. The 2008 BIO Convention in San Diego this month will provide the perfect opportunity for...
In what is being described as a powerful technology combination, Madison's Gentel Biosciences will team with Germany's Eppendorf AG under a license-and-supply agreement designed to advance protein array applications. With the deal, Gentel adds to its intellectual property footprint and gains access to new markets...
The global medical device industry is even more robust than big pharma but there is a real synergy developing between the two that is important to the Midwestern states that boast of a strong medical device industry, notes columnist Michael Rosen. In this edition of...
Two Wisconsin companies will present to a gathering of 20,000 industry representatives and investors at the forthcoming 2008 BIO International Convention in San Diego. Invivosciences of Milwaukee and Primorigen Biosciences of McFarland will make formal presentations about their companies during the four-day event, which begins...
The Madison-based BellBrook Labs, a developer of drug discovery tools, has received additional patent protection for its drug discovery platform. This is the second and third patents for the high-throughput technology known as Transcreener, which is used for large-scale screening by manufacturing and biotechnology companies,...
aOva Technologies, a Madison-based agricultural-biotechnology company, has launched another investment round in hopes raising more than $3 million in angel capital. The company, founded in 2001, would use the money to expand its ability to sell egg protein products used in animal feed to grow...
While some bemoan any hype surrounding human embryonic stem cell research, the truth is that we're fast approaching the day when stem cells will be used in experimental threrapies of human diseases, notes columnist Steve Clark. In this edition of Biotech Takes, Clark updates Wisconsinites...